Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Ascendis Pharma (ASND)
NASDAQ:ASND
Holding ASND?
Track your performance easily
See the Price Targets and Ratings of:
ASND Analyst Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ASND Stock 12 Month Forecast
Average Price Target
$190.85
▲(54.07% Upside)
| Highest Price Target$289.00 | Average Price Target$190.85 | Lowest Price Target$153.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
11/18/24
Leerink Partners
Reiterated
11/15/24
TD Cowen
Assigned
11/15/24
J.P. Morgan
Reiterated
11/15/24
Stifel Nicolaus
Reiterated
11/15/24
Citi
Reiterated
11/15/24
Bank of America Securities
Reiterated
11/15/24
Oppenheimer
Reiterated
11/15/24
Wedbush
Reiterated
11/15/24
Wells Fargo
Reiterated
11/14/24
Cantor Fitzgerald
$170
Buy
37.24%
Upside
Reiterated
11/04/24
Ascendis Pharma (ASND) Receives a Buy from Cantor Fitzgerald
Goldman Sachs
$180→$200
Buy
61.46%
Upside
Reiterated
09/16/24
Ascendis Pharma Receives Buy Rating Amid Positive Phase 3 Results for TransCon CNP
Jefferies
$179
Buy
44.51%
Upside
Assigned
09/16/24
Ascendis Pharma (ASND) PT Raised to $179 at JefferiesJefferies analyst Kelly Shi raised the price target on Ascendis Pharma (NASDAQ: ASND) to $179.00 (from $174.00) while maintaining a Buy rating.
―
Evercore ISI
―
Buy
―
Assigned
11/15/24
We’ll go through the 5 things that matter most to the stock, you’ll need to click inside for details. (note: see our virtual fireside with Jan/Scott a couple weeks ago where we went into more detail on these points) Big picture: ASND’s stock is set up for a strong 2025, and we think the current valuation offers a very attractive entry point. With some model changes PT remains $205/sh.
Best Analysts Covering Ascendis Pharma
Which Analyst Should I Follow If I Want to Buy ASND and Sell After:
1 Month
xxx
Success Rate
19/27 ratings generated profit
Average Return
+3.70%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 70.37% of your transactions generating a profit, with an average return of +3.70% per trade.
3 Months
xxx
Success Rate
14/22 ratings generated profit
Average Return
+10.18%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 63.64% of your transactions generating a profit, with an average return of +10.18% per trade.
1 Year
Success Rate
16/27 ratings generated profit
Average Return
+21.05%
reiterated a buy rating 7 days ago
Copying Tazeen Ahmad's trades and holding each position for 1 Year would result in 59.26% of your transactions generating a profit, with an average return of +21.05% per trade.
2 Years
xxx
Success Rate
17/22 ratings generated profit
Average Return
+21.92%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 77.27% of your transactions generating a profit, with an average return of +21.92% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ASND Analyst Recommendation Trends
Rating
Jul 24
Aug 24
Sep 24
Oct 24
Nov 24
Strong Buy
3
4
12
11
14
Buy
17
8
23
25
29
Hold
11
11
11
10
9
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
23
46
46
52
Each month's total comprises the sum of three months' worth of ratings.
ASND Financial Forecast
ASND Stock Forecast FAQ
What is ASND’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is $190.85.
What is ASND’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 54.07% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ASND a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s price target?
The average price target for Ascendis Pharma is $190.85. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $289.00 ,the lowest forecast is $153.00. The average price target represents 54.07% Increase from the current price of $123.87.
The highest analyst price target is $289.00 ,the lowest forecast is $153.00. The average price target represents 54.07% Increase from the current price of $123.87.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of ASND?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.